Ampio Pharma (AMPE) Believes Short-Seller Allegations are 'Factually Inaccurate'
Tweet
Share
E-mailGet Alerts AMPE Hot Sheet
Join SI Premium – FREE
Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE) has issued a statement in response to recent publications about the Company by anonymous short sellers. The Company believes increased volatility and volume in its common stock is a result of factually inaccurate and materially misleading information being published on the internet about the Company. These anonymous publications disclose that the authors stand to benefit financially from a decline in Ampio's stock.
The Company is investigating the claims that were made and is evaluating potential legal recourse to protect the shareholders and officers of the Company.
The Company is investigating the claims that were made and is evaluating potential legal recourse to protect the shareholders and officers of the Company.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sky Quarry names Heidi Bowman as CFO
- Solana Company announces votes on first Solana governance proposals
- WiMi proposes quantum convolutional neural network for data tasks
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
